XYLOCAINE PUMP SPRAY 10%

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Active ingredient:

LIDOCAINE

Available from:

DCH AURIGA SINGAPORE

ATC code:

N01BB02

Dosage:

10 mg/dose

Pharmaceutical form:

SPRAY

Composition:

LIDOCAINE 10 mg/dose

Administration route:

TOPICAL

Prescription type:

Pharmacy Only

Manufactured by:

ASTRAZENECA AB

Authorization status:

ACTIVE

Authorization date:

1992-04-27

Patient Information leaflet

Composition
Active constituent:
1 dose Xylocaine pump spray contains: Lidocaine base 10 mg.
For excipients see List of excipients.
Pharmaceutical form
Cutaneous spray, solution
The solution is a clear to almost clear, slightly pink-coloured liquid
with menthol and banana flavour.
Therapeutic indications
For the prevention of pain associated with the following
procedures:
Otorhinolaryngology
- Puncture of the maxillary sinus and minor surgical procedures
in the oral and nasal cavity, pharynx and epipharynx.
Obstetrics
During the final stages of delivery and before episiotomy and
perineal suturing as supplementary pain control.
Introduction of instruments, tubes and catheters into the
respiratory and digestive tract
Provides surface anaesthesia for the oropharyngeal and
tracheal areas to reduce reflex activity, attenuate haemodynamic
responses and facilitate insertion of the tube or the passage
of instruments during endotracheal intubation and endoscopic
procedures of the airways and upper gastrointestinal tract.
Dental practice
Before injections, dental impressions, X-ray photography, removal
of calculus.
Posology and method of administration
Xylocaine spray is intended for use on mucous membranes
and provides efficient surface anaesthesia, which lasts for
approximately 10-15 minutes. The anaesthesia usually occurs
within 1-5 minutes, depending on the area of application.
As with any local anaesthetic, the safety and effectiveness of
lidocaine depend on the proper dosage, the correct technique,
adequate precautions and readiness for emergencies.
The following dosage recommendations should be regarded as a
guide. The clinician’s experience and knowledge of the patient’s
physical status are of importance in calculating the required dose.
The degree of absorption from mucous membranes is variable
but especially high from the bronchial tree. Application only to
areas below the vocal cords may result in excessive plasma
concentrations because of less transfer to the intestine and less
first-pass loss.
Each actuatio

Summary of Product characteristics

Xylocaine Pump Spray 10% (10 mg/spray dose)
_lidocaine _
PUMP SPRAY FOR TOPICAL ANAESTHESIA
COMPOSITION
Active constituent:
1 dose Xylocaine pump spray contains: Lidocaine base 10 mg.
For excipients see List of excipients.
PHARMACEUTICAL FORM
Cutaneous spray, solution
The solution is a clear to almost clear, slightly pink-coloured liquid
with menthol and banana flavour.
THERAPEUTIC INDICATIONS
For the prevention of pain associated with the following procedures:
_Otorhinolaryngology _
- Puncture of the maxillary sinus and minor surgical procedures in the
oral and nasal cavity, pharynx and
epipharynx.
_Obstetrics _
During the final stages of delivery and before episiotomy and
perineal suturing as supplementary pain control.
_Introduction of instruments, tubes and catheters into the respiratory
and digestive tract _
Provides surface anaesthesia for the oropharyngeal and tracheal areas
to reduce reflex activity, attenuate
haemodynamic responses and facilitate insertion of the tube or the
passage of instruments during endotracheal
intubation and endoscopic procedures of the airways and upper
gastrointestinal tract.
_Dental practice _
Before injections, dental impressions, X-ray photography, removal of
calculus.
POSOLOGY AND METHOD OF ADMINISTRATION
Xylocaine pump spray provides surface anaesthesia of mucous membranes,
which lasts for approximately 10-
15 minutes. The anaesthesia usually occurs within 1-5 minutes,
depending on the area of application.
As with any local anaesthetic, the safety and effectiveness of
lidocaine depend on the proper dosage, the
correct technique, adequate precautions and readiness for emergencies.
The following dosage recommendations should be regarded as a guide.
The clinician’s experience and
knowledge of the patient’s physical status are of importance in
calculating the required dose.
The degree of absorption from mucous membranes is variable but
especially high from the bronchial tree.
Application only to areas below the vocal cords may result in
excessive plasma concentrations be